Literature DB >> 8557665

Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis.

Y R Chen1, C F Meyer, T H Tan.   

Abstract

The c-Jun N-terminal kinases (JNK) are activated by various stimuli, including UV light, interleukin-1, tumor necrosis factor-alpha (TNF-alpha), and CD28 costimulation. Induction of JNK by TNF-alpha, a strong apoptosis inducer, implies a possible role of JNK in the regulation of programmed cell death. Present studies show that lethal doses of gamma radiation (GR) induced JNK activities at the early phase of apoptosis in Jurkat T-cells. We demonstrate that JNK1 was activated by either the T-cell activation signals, anti-CD28 monoclonal antibody plus phorbol 12-myristate 13-acetate (PMA), or the apoptosis-inducing treatment, GR; however, the induction patterns were different. In contrast to the rapid and transient JNK1 activation caused by CD28 signaling plus PMA, GR induced a delayed and persistent JNK1 activation. This implies a distinct regulatory mechanism and specific function of JNK1 in irradiated cells. The nuclear and cytosolic JNK1 activities were simultaneously increased in the irradiated cells without an evident change in the protein levels. The abilities of GR to induce JNK1 activation and DNA fragmentation were correlated. Peripheral blood lymphocytes were more sensitive to GR than Jurkat cells in JNK1 induction. The responsiveness of JNK1 to GR suggests the involvement of JNK1 in the initiation of the apoptosis process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557665     DOI: 10.1074/jbc.271.2.631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Apoptosis: A Current Molecular Analysis.

Authors:  Dean G Tang; Arthur T Porter
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Heat shock and ceramide have different apoptotic pathways in radiation induced fibrosarcoma (RIF) cells.

Authors:  Hee-Jung Kim; Kong-Joo Lee
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis.

Authors:  D D Mosser; A W Caron; L Bourget; C Denis-Larose; B Massie
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.

Authors:  I Herr; D Wilhelm; T Böhler; P Angel; K M Debatin
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

Review 5.  Nicotinic modulation of hippocampal cell signaling and associated effects on learning and memory.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Physiol Behav       Date:  2015-12-11

6.  Activation of Ntf4, a tobacco mitogen-activated protein kinase, during plant defense response and its involvement in hypersensitive response-like cell death.

Authors:  Dongtao Ren; Kwang-Yeol Yang; Guo-Jing Li; Yidong Liu; Shuqun Zhang
Journal:  Plant Physiol       Date:  2006-06-23       Impact factor: 8.340

7.  Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.

Authors:  Pamela Cameron; Susan J Smith; Mark A Giembycz; Dino Rotondo; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

8.  Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter.

Authors:  M Faris; K M Latinis; S J Kempiak; G A Koretzky; A Nel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status.

Authors:  Sampa Ghose; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.